Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 319

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 319
---
 based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013 Framework). Based on this assessment, our management concluded that our internal control over financial reporting was not effective as of December 31, 2023, due to the existence of material weaknesses in our internal control over financial reporting. These material weaknesses are described below:

| 1. | Inadequate                                                                                   
 Design of Policies and Procedures: We did not design policies and procedures at a sufficient 
 level of precision to support the operating effectiveness of controls to prevent and detect  
 potential errors.                                                                            |

| 2. | Lack                                                                                     
 of Documentation: There was a failure to maintain adequate documentation to evidence     
 the operating effectiveness of certain control activities and a lack of proper levels of 
 supervision and review of complex accounting matters.                                    |

| 3. | Access                                                                                         
 Control and Segregation of Duties: Inadequate controls in place related to maintaining         
 appropriate access to certain systems and maintaining appropriate segregation of duties within 
 those systems.                                                                                 |

F-71 Management has undertaken a remediation plan to address these material weaknesses. During the year ended December 31, 2023, we continued to enhance our internal control over financial reporting through various initiatives, including investing in information technology systems, enhancing the organizational structure, providing guidance and training to employees and further developing detailed policies and procedures. We expect to remediate these material weaknesses in the first half of 2025. However, there may be additional material weaknesses identified that could require additional time and resources to remediate. We remain committed to ensuring that our internal control over financial reporting is designed and operating effectively. We acknowledge the deficiencies in our internal control over financial reporting and are actively working towards remediation and improvement. We will continue to monitor and evaluate the effectiveness of our internal control over financial reporting to ensure timely and accurate financial reporting. Attestation Report on Internal Control over Financial Reporting This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm due to the deferral allowed under the Jumpstart Our Business Startups Act of 2012 for emerging growth companies. Changes in Internal Control over Financial Reporting Other than with respect to the remediation efforts discussed above, there was no change in our internal control over financial reporting that occurred during 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. F-72 Up to 3,735,977 Shares of